Initial general form for registration of a class of securities pursuant to Section 12(g)

Description of Business (Details Narrative)

v3.21.4
Description of Business (Details Narrative) - USD ($)
1 Months Ended
Jun. 25, 2021
Jun. 09, 2021
Sep. 30, 2021
Jun. 30, 2021
Jun. 30, 2020
Voting percent   51.00%      
Working capital deficit     $ 2,600,000 $ 2,200,000  
Accumulated deficit     $ 32,984,558 $ 32,688,198 $ 32,180,430
Mr Gerard Dab [Member] | Chief Executive Officer [Member]          
Convertible Notes Payable, Current   $ 200,000      
Stock Issued During Period, Shares, Conversion of Convertible Securities   14,465,259      
Series B Convertible Redeemable Preferred Stock [Member]          
Percentage of shares for conversion 4.99%        
Series A Supermajority Voting Preferred Stock [Member]          
Stock Issued During Period, Shares, Acquisitions   1,000      
Series A Supermajority Voting Preferred Stock [Member] | Mr Gerard Dab [Member]          
Stock Issued During Period, Value, Acquisitions   $ 300,000      
Series C Convertible Redeemable Preferred Stock [Member]          
Stock Issued During Period, Shares, Acquisitions   200      
Rennova Health Inc [Member] | Series B Convertible Redeemable Preferred Stock [Member]          
Sale of stock, number of shares issued 14,000   950    
Preferred stock stated value $ 1,000